Thus, in addition to a comprehensive approach encompassing multidisciplinary risk factors (dyslipidaemia, hypertension, obesity, smoking, etc.) [8, 9], considering "what drugs to use to lower blood glucose" by selecting hypoglycaemic agents with evidence-based cardiorenal protective effects, according to patient background and risk status is increasingly important [10]
Treatment evolves as progress is made, ensuring that each patient continues moving toward their goals at a safe, sustainable pace
Compounded Options for Enhanced Accessibility Telehealth providers may also offer another important option: compounded versions of tirzepatide and semaglutide
Daily fructose consumption has doubled in the past 30 years in the US, a pattern also observable (though not identical) here, in Canada, Malaysia, India, right across the developed and developing world